article · Annales Africaines de Medecine
Context and objective. Patients with ischemic heart disease (IHD) and severe left ventricular dysfunction (LVD) are at high risk of sudden cardiac death (SCD). Implantable cardioverter-defibrillators (ICDs) reduce this risk but are typically considered only after reassessing left ventricular ejection fraction (LVEF) three months post-discharge. The present study aimed to identify predictors of ICD implantation in patients with IHD and severe LVD. Methods. This was a retrospective cohort study including adult patients (≥ 18 years) with IHD and LVEF < 35%, hospitalized between January 2020 and August 2024 at the Centre Hospitalier Sud Francilien (CHSF). All were discharged with a wearable cardioverter defibrillator (WCD), and reassessed after 3 months. Multivariate logistic regression was used to identify factors associated with ICD implantation. Results. Among 123 patients, 51 (41.5%) underwent ICD implantation. Factors independently associated with ICD implantation included Age ≥ 60 years, hypertension (aOR 2.52; 95% CI: 1.57–5.99), early revascularization (aOR 2.89; 95% CI: 1.82–5.34), sustained ventricular tachycardia (aOR 3.60; 95% CI: 1.97–5.23), and LVEF ≤ 20% (aOR 3.39; 95% CI: 1.92–9.38). Conclusion. In IHD patients with severe LVD, several factors may guide early identification of candidates for ICD implantation. Received: February 17th ,2025 Accepted: March 29th, 2025 https://dx.doi.org/10.4314/aamed.v18i4.5
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.4314/aamed.v18i4.5
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.